Seeing Is Believing

Currently out of the existing stock ratings of Marie Thibault, 246 are a BUY (93.18%), 18 are a HOLD (6.82%).
Analyst Marie Thibault, currently employed at BTIG, carries an average stock price target met ratio of 49.59% that have a potential upside of 39.81% achieved within 169 days.
Marie Thibault’s has documented 506 price targets and ratings displayed on 29 stocks. The coverage is on Healthcare, Consumer Cyclical sectors.
Most recent stock forecast was given on ABT, Abbott Laboratories at 21-Oct-2026.
Analyst best performing recommendations are on STIM (NEURONETICS).
The best stock recommendation documented was for STIM (NEURONETICS) at 1/21/2021. The price target of $21 was fulfilled within 1 day with a profit of $2.58 (14.01%) receiving and performance score of 140.07.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 28-Jun-2017
$120
$16.3 (15.72%)
$112
Buy Since 05-Jun-2019
$122
$18.3 (17.65%)
$112
6 days ago
(21-Oct-2026)
25/33 (75.76%)
$19.49 (19.01%)
420
Buy Since 22-Oct-2018
$118
$14.3 (13.79%)
$120
6 days ago
(21-Oct-2026)
10/14 (71.43%)
$15.49 (15.11%)
354
Buy Since 01-Jun-2021
$125
$21.3 (20.54%)
$134
6 days ago
(21-Oct-2026)
8/25 (32%)
$22.49 (21.94%)
406
Buy Since 22-Jan-2017
$118
$14.3 (13.79%)
$135
6 days ago
(21-Oct-2026)
26/41 (63.41%)
$15.49 (15.11%)
336
Which stock is Marie Thibault most bullish on?
Which stock is Marie Thibault most reserved on?
What Year was the first public recommendation made by Marie Thibault?